Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,872.16
      -2.95%
      US Tech 100
      20,650.40
      -3.65%
      Dow Jones
      42,326.87
      -2.58%
      Brent Oil
      72.735
      0.00%
      Bitcoin
      100,756.66
      0.69%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSXV

      6. Rakovina Therapeutics Inc (RKV) Quote

      Rakovina Therapeutics Inc

      Rakovina Therapeutics Inc (RKV)

      TSXV
      0.15
      0.02
      (15.38%)
      Closed December 18 4:00PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.15
      Bid
      0.14
      Ask
      0.15
      Volume
      597,975
      0.14 Day's Range 0.15
      0.005 52 Week Range 0.15
      Market Cap
      10.513M
      Previous Close
      0.13
      Open
      0.15
      Last Trade
      500
      @
      0.15
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      173,905
      Shares Outstanding
      70,084,000
      Dividend Yield
      -
      PE Ratio
      -5.36
      Earnings Per Share (EPS)
      -0.04
      Revenue
      -
      Net Profit
      -2.61M

      About Rakovina Therapeutics Inc

      Sector
      Unit Inv Tr, Closed-end Mgmt
      Industry
      Unit Inv Tr, Closed-end Mgmt
      Website
      www.rakovinatherapeutics.com
      Headquarters
      Vancouver, British Columbia, Can
      Founded
      -
      Rakovina Therapeutics Inc is listed in the Unit Inv Tr, Closed-end Mgmt sector of the TSX Venture Exchange with ticker RKV. The last closing price for Rakovina Therapeutics was $0.13. Over the last year, Rakovina Therapeutics shares have traded in a share price range of $ 0.005 to $ 0.15.

      Rakovina Therapeutics currently has 70,084,000 shares outstanding. The market capitalization of Rakovina Therapeutics is $9.11 million. Rakovina Therapeutics has a price to earnings ratio (PE ratio) of -5.36.

      Ask ADVFN Intelligence (AI)

      RKV Latest News

      More News

      Rakovina Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations

      VANCOUVER, British Columbia, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) announces that in accordance with the terms of an indenture...

      21 hours ago
      GlobeNewswire Inc.

      Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement

      VANCOUVER, British Columbia, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”, “Rakovina”, or “Rakovina Therapeutics”) a biopharmaceutical company...

      December 13 2024
      GlobeNewswire Inc.

      Rakovina Therapeutics Announces Presentation at the 13th Annual Tumour Models London Summit

      VANCOUVER, British Columbia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”), a biopharmaceutical company committed to advancing new...

      December 03 2024
      GlobeNewswire Inc.

      Rakovina Therapeutics Increases Private Placement Offering to $3.0 Million

      VANCOUVER, British Columbia, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to...

      December 02 2024
      GlobeNewswire Inc.

      Rakovina Therapeutics Announces 2024 Q3 Financial Results and Provides Corporate Update

      VANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed to advancing new cancer therapies...

      November 29 2024
      GlobeNewswire Inc.

      Rakovina Therapeutics Announces Increase in Private Placement Offering to $2.5 Million

      VANCOUVER, British Columbia, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to...

      November 28 2024
      GlobeNewswire Inc.

      Rakovina Therapeutics Announces Private Placement Offering

      VANCOUVER, British Columbia, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to...

      November 27 2024
      GlobeNewswire Inc.

      Rakovina Therapeutics Presents AI-Driven Drug Discovery Research at Society for Neuro-Oncology Annual Meeting

      VANCOUVER, British Columbia, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”), a biopharmaceutical company committed to advancing new...

      November 25 2024
      GlobeNewswire Inc.

      Rakovina Therapeutics Announces Upcoming Poster Presentation at the 29th Annual Society for Neuro-Oncology Meeting in Houston, Texas

      VANCOUVER, British Columbia, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”), a biopharmaceutical company committed to advancing new...

      November 20 2024
      GlobeNewswire Inc.

      Rakovina Therapeutics to Present Research Highlighting Small-Molecule Bifunctional Inhibitors of PARP1/2 and HDAC Enzymes at the 36th EORTC-NCI-AACR Symposium in Barcelona Spain

      VANCOUVER, British Columbia, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”), a biopharmaceutical company committed to advancing new...

      October 25 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.017.142857142860.140.150.1052313710.13637292CS
      40.085130.7692307690.0650.150.0453291250.09667831CS
      120.0666.66666666670.090.150.0451739050.09076842CS
      260.0436.36363636360.110.150.045979580.09130162CS
      520.0787.50.080.150.005731010.09074356CS
      156-0.05-250.20.250.005361800.11300794CS
      260-0.1-400.250.3950.005372350.13176064CS

      RKV - Frequently Asked Questions (FAQ)

      What is the current Rakovina Therapeutics share price?
      The current share price of Rakovina Therapeutics is $ 0.15
      How many Rakovina Therapeutics shares are in issue?
      Rakovina Therapeutics has 70,084,000 shares in issue
      What is the market cap of Rakovina Therapeutics?
      The market capitalisation of Rakovina Therapeutics is CAD 9.11M
      What is the 1 year trading range for Rakovina Therapeutics share price?
      Rakovina Therapeutics has traded in the range of $ 0.005 to $ 0.15 during the past year
      What is the PE ratio of Rakovina Therapeutics?
      The price to earnings ratio of Rakovina Therapeutics is -5.36
      What is the reporting currency for Rakovina Therapeutics?
      Rakovina Therapeutics reports financial results in CAD
      What is the latest annual profit for Rakovina Therapeutics?
      The latest annual profit of Rakovina Therapeutics is CAD -2.61M
      What is the registered address of Rakovina Therapeutics?
      The registered address for Rakovina Therapeutics is 720,999 WEST BROADWAY, VANCOUVER, BRITISH COLUMBIA, V5Z1K5
      What is the Rakovina Therapeutics website address?
      The website address for Rakovina Therapeutics is www.rakovinatherapeutics.com
      Which industry sector does Rakovina Therapeutics operate in?
      Rakovina Therapeutics operates in the UNIT INV TR, CLOSED-END MGMT sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      OEG.HONEnergy Inc
      $ 0.085
      (1,600.00%)
      		45.54k
      DMDataMetrex AI Limited
      $ 0.01
      (100.00%)
      		227.13k
      NIKL.HGK Resources LTD
      $ 0.09
      (100.00%)
      		26.8k
      TVC.HThree Valley Copper Corp
      $ 0.01
      (100.00%)
      		1.9k
      RCTRochester Resources Ltd
      $ 0.025
      (66.67%)
      		10k
      AAAJ.PAAJ Capital 3 Corp
      $ 0.035
      (-58.82%)
      		50k
      CHSComprehensive Healthcare Systems Inc
      $ 0.005
      (-50.00%)
      		1M
      ETUE2gold Inc
      $ 0.005
      (-50.00%)
      		10k
      ALTAlturas Minerals Corp
      $ 0.005
      (-50.00%)
      		10k
      BOCABocana Resources Corp
      $ 0.005
      (-50.00%)
      		38.86k
      THRMTherma Bright Inc
      $ 0.03
      (20.00%)
      		8.98M
      QNCQuantum Emotion Corp
      $ 0.44
      (-35.29%)
      		8.08M
      GPUSAlset AI Ventures Inc
      $ 0.11
      (15.79%)
      		7.56M
      MATEBlockmate Ventures Inc
      $ 0.225
      (-21.05%)
      		7.4M
      SPCSPC Nickel Corp
      $ 0.02
      (0.00%)
      		4.15M

      Discussion

      View Full Feed
      FlyingDutchman FlyingDutchman 4 minutes ago
      opening new site and I'll show you what 20 yrs gets you
      J.Lummouxx J.Lummouxx 5 minutes ago
      So don't use a stop loss order to take some profit because the price can keep going up after the sell? But you keep looking for congratulations here for taking your profit while the stock ran up another 10 bucks. So what is it? You seem to be contradicting yourself 
      SOUN
      thetinman thetinman 5 minutes ago
      Lmao !! What does the fed have to do with BTZI? absolutely NOTHING!!

      Apparently a distraction from PUMPING btzi up to .36 cents🤣🤣
      BTZI
      qualityincolor qualityincolor 5 minutes ago
      Someone bought up a bunch of shares in the trips and now they're using them to control the action imo. They get bought out and we'll move
      RDAR
      FlyingDutchman FlyingDutchman 6 minutes ago
      you still don't get it
      Investor082 Investor082 6 minutes ago
      None of these trials will get off the ground in 2025 because they have no money. It will be a nothing burger like the Direct trial announcement they made back in 2017. Pump and dump scheme. But then blame it on shorts and market makers for their inability to raise capital at better valuation.
      NWBO
      TenKay TenKay 6 minutes ago
      I haven’t followed in awhile.
      FlyingDutchman FlyingDutchman 7 minutes ago
      TGHL please stop with your bb post. kinda like CETX this boards fav's hows your ATXI piggy doing? here caturd?
      ATXI CETX
      TenKay TenKay 7 minutes ago
      The question is who is the wizard behind the curtain? Dennis isn’t that smart.
      DPLS
      Invest-in-America Invest-in-America 7 minutes ago
      CURR: Evidently, only ONE iHuber (on Orion's Board) --- and myself, who created this CURR Board --- posted anything about this HUGELY-SOARING beast late in this Wall Street day.
      CURR
      wickw50 wickw50 7 minutes ago
      Somebody loading 31 million at 3's... if it continues tomorrow... we may have a merger...
      ETEK
      Techroemancer Techroemancer 7 minutes ago
      He misses the social interaction we provide him and courteously provides the same for us. Ours is a bit more articulate and we happen to cite a whole lot more sources than Steal, but he's growing on me. Starting to not even care about his lies so much anymore. I just get a little humor from it daily
      MGON
      carlson carlson 7 minutes ago
      When was our last PR?
      NBRI
      LowFloatLopes LowFloatLopes 8 minutes ago
      That's a good point bud 
      NUKK
      MartinLutherKing MartinLutherKing 9 minutes ago
      All aboard 🚀🚀🚀🚀🚀🚀
      ELAB
      4C 4C 9 minutes ago
      Buy: 165,979 Neutral: 732,729 Sell: 271,000
      UNVC
      MartinLutherKing MartinLutherKing 10 minutes ago
      It’s already here brother 🚀🚀🚀
      ELAB
      Buckey Buckey 10 minutes ago
      Oh boy getting rid of the French lol. The idea warming to me.
      TenKay TenKay 11 minutes ago
      They pick some low hanging fruit…
      Mojocash Mojocash 11 minutes ago
      Back in just now!!! Yes!
      NUKK
      rogers711 rogers711 12 minutes ago
      Are any others investors concerned with the continued expansion of isopet when it's not generating hardly any revenue? I understand it needs to be expanded to have potential for large revenue but there seems to be hardly any demand... thoughts? 
      RDGL
      Pennyboy20 Pennyboy20 13 minutes ago
      lol, that’s an opinion, just not one I was thinking. One can’t argue the lack of transparency.
      IBGR
      tdbowieknife tdbowieknife 13 minutes ago
      So, you think a decades old penny stock serial scam with no assets at all, is worth several million bucks??

      Lol...

      He could go public on his own for much, much less, and it would be clean without the fraud baggage. It makes NO seance at all for a legit company to get
      GRLT
      ANTI-BAGHOLDER ANTI-BAGHOLDER 14 minutes ago
      “MyPressAlert.com will do what the website discusses.“

      There is some crazy detail on that website.
      MONI

      Your Recent History

      TSXV
      RKV
      Rakovina Therapeutics
      Delayed Upgrade Clock